Valley Wealth Managers Inc. Purchases 174 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Valley Wealth Managers Inc. grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 14.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,383 shares of the company’s stock after acquiring an additional 174 shares during the quarter. Valley Wealth Managers Inc.’s holdings in HCA Healthcare were worth $562,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of the stock. Bangor Savings Bank increased its position in shares of HCA Healthcare by 112.5% in the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after acquiring an additional 45 shares during the period. MFA Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare during the second quarter worth about $27,000. Unique Wealth Strategies LLC purchased a new position in HCA Healthcare during the 2nd quarter worth approximately $28,000. GPS Wealth Strategies Group LLC lifted its position in HCA Healthcare by 284.0% during the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares during the period. Finally, Benjamin F. Edwards & Company Inc. acquired a new stake in HCA Healthcare during the 2nd quarter worth about $33,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now directly owns 52,702 shares in the company, valued at $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 15,155 shares of company stock worth $5,608,990. 1.60% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

HCA has been the topic of several analyst reports. TD Cowen dropped their target price on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a report on Monday, October 28th. Royal Bank of Canada lifted their price target on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research note on Friday, August 23rd. Oppenheimer raised their price objective on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a report on Monday, October 28th. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Finally, Leerink Partners upped their price objective on shares of HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Five analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $385.00.

HCA Healthcare Price Performance

Shares of HCA opened at $342.96 on Friday. The company has a market cap of $86.87 billion, a P/E ratio of 15.40, a PEG ratio of 1.34 and a beta of 1.68. The firm’s 50 day moving average price is $385.11 and its 200 day moving average price is $357.25. HCA Healthcare, Inc. has a fifty-two week low of $238.82 and a fifty-two week high of $417.14. The company has a quick ratio of 1.00, a current ratio of 1.12 and a debt-to-equity ratio of 48.71.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be given a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.77%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.